Cargando…

Identification of glomerulosclerosis using IBM Watson and shallow neural networks

BACKGROUND: Advanced stages of different renal diseases feature glomerular sclerosis at a histological level which is observed by light microscopy on tissue samples obtained by performing a kidney biopsy. Computer-aided diagnosis (CAD) systems leverage the potential of artificial intelligence (AI) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pesce, Francesco, Albanese, Federica, Mallardi, Davide, Rossini, Michele, Pasculli, Giuseppe, Suavo-Bulzis, Paola, Granata, Antonio, Brunetti, Antonio, Cascarano, Giacomo Donato, Bevilacqua, Vitoantonio, Gesualdo, Loreto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765108/
https://www.ncbi.nlm.nih.gov/pubmed/35041197
http://dx.doi.org/10.1007/s40620-021-01200-0
_version_ 1784634295334207488
author Pesce, Francesco
Albanese, Federica
Mallardi, Davide
Rossini, Michele
Pasculli, Giuseppe
Suavo-Bulzis, Paola
Granata, Antonio
Brunetti, Antonio
Cascarano, Giacomo Donato
Bevilacqua, Vitoantonio
Gesualdo, Loreto
author_facet Pesce, Francesco
Albanese, Federica
Mallardi, Davide
Rossini, Michele
Pasculli, Giuseppe
Suavo-Bulzis, Paola
Granata, Antonio
Brunetti, Antonio
Cascarano, Giacomo Donato
Bevilacqua, Vitoantonio
Gesualdo, Loreto
author_sort Pesce, Francesco
collection PubMed
description BACKGROUND: Advanced stages of different renal diseases feature glomerular sclerosis at a histological level which is observed by light microscopy on tissue samples obtained by performing a kidney biopsy. Computer-aided diagnosis (CAD) systems leverage the potential of artificial intelligence (AI) in healthcare to support physicians in the diagnostic process. METHODS: We propose a novel CAD system that processes histological images and discriminates between sclerotic and non-sclerotic glomeruli. To this goal, we designed, tested, and compared two artificial neural network (ANN) classifiers. The former implements a shallow ANN classifying hand-crafted features extracted from Regions of Interest (ROIs) by means of image-processing procedures. The latter, instead, employs the IBM Watson Visual Recognition System, which uses a deep artificial neural network making decisions taking the images as input, without the need to design any procedure for describing images with features. The input dataset consisted of 428 sclerotic glomeruli and 2344 non-sclerotic glomeruli derived from images of kidney biopsies scanned by the Aperio ScanScope System. RESULTS: Both AI approaches allowed to very accurately distinguish (mean MCC 0.95 and mean Accuracy 0.99) between sclerotic and non-sclerotic glomeruli. Although the systems may seem interchangeable, the approach based on feature extraction and classification would allow clinicians to gain information on the most discriminating features. In fact, further procedures could explain the classifier’s decision by analysing which subset of features impacted the most on the final decision. CONCLUSIONS: We developed a customizable support system that can facilitate the work of renal pathologists both in clinical and research settings. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40620-021-01200-0.
format Online
Article
Text
id pubmed-8765108
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-87651082022-01-18 Identification of glomerulosclerosis using IBM Watson and shallow neural networks Pesce, Francesco Albanese, Federica Mallardi, Davide Rossini, Michele Pasculli, Giuseppe Suavo-Bulzis, Paola Granata, Antonio Brunetti, Antonio Cascarano, Giacomo Donato Bevilacqua, Vitoantonio Gesualdo, Loreto J Nephrol original Article BACKGROUND: Advanced stages of different renal diseases feature glomerular sclerosis at a histological level which is observed by light microscopy on tissue samples obtained by performing a kidney biopsy. Computer-aided diagnosis (CAD) systems leverage the potential of artificial intelligence (AI) in healthcare to support physicians in the diagnostic process. METHODS: We propose a novel CAD system that processes histological images and discriminates between sclerotic and non-sclerotic glomeruli. To this goal, we designed, tested, and compared two artificial neural network (ANN) classifiers. The former implements a shallow ANN classifying hand-crafted features extracted from Regions of Interest (ROIs) by means of image-processing procedures. The latter, instead, employs the IBM Watson Visual Recognition System, which uses a deep artificial neural network making decisions taking the images as input, without the need to design any procedure for describing images with features. The input dataset consisted of 428 sclerotic glomeruli and 2344 non-sclerotic glomeruli derived from images of kidney biopsies scanned by the Aperio ScanScope System. RESULTS: Both AI approaches allowed to very accurately distinguish (mean MCC 0.95 and mean Accuracy 0.99) between sclerotic and non-sclerotic glomeruli. Although the systems may seem interchangeable, the approach based on feature extraction and classification would allow clinicians to gain information on the most discriminating features. In fact, further procedures could explain the classifier’s decision by analysing which subset of features impacted the most on the final decision. CONCLUSIONS: We developed a customizable support system that can facilitate the work of renal pathologists both in clinical and research settings. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40620-021-01200-0. Springer International Publishing 2022-01-18 2022 /pmc/articles/PMC8765108/ /pubmed/35041197 http://dx.doi.org/10.1007/s40620-021-01200-0 Text en © Italian Society of Nephrology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle original Article
Pesce, Francesco
Albanese, Federica
Mallardi, Davide
Rossini, Michele
Pasculli, Giuseppe
Suavo-Bulzis, Paola
Granata, Antonio
Brunetti, Antonio
Cascarano, Giacomo Donato
Bevilacqua, Vitoantonio
Gesualdo, Loreto
Identification of glomerulosclerosis using IBM Watson and shallow neural networks
title Identification of glomerulosclerosis using IBM Watson and shallow neural networks
title_full Identification of glomerulosclerosis using IBM Watson and shallow neural networks
title_fullStr Identification of glomerulosclerosis using IBM Watson and shallow neural networks
title_full_unstemmed Identification of glomerulosclerosis using IBM Watson and shallow neural networks
title_short Identification of glomerulosclerosis using IBM Watson and shallow neural networks
title_sort identification of glomerulosclerosis using ibm watson and shallow neural networks
topic original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765108/
https://www.ncbi.nlm.nih.gov/pubmed/35041197
http://dx.doi.org/10.1007/s40620-021-01200-0
work_keys_str_mv AT pescefrancesco identificationofglomerulosclerosisusingibmwatsonandshallowneuralnetworks
AT albanesefederica identificationofglomerulosclerosisusingibmwatsonandshallowneuralnetworks
AT mallardidavide identificationofglomerulosclerosisusingibmwatsonandshallowneuralnetworks
AT rossinimichele identificationofglomerulosclerosisusingibmwatsonandshallowneuralnetworks
AT pasculligiuseppe identificationofglomerulosclerosisusingibmwatsonandshallowneuralnetworks
AT suavobulzispaola identificationofglomerulosclerosisusingibmwatsonandshallowneuralnetworks
AT granataantonio identificationofglomerulosclerosisusingibmwatsonandshallowneuralnetworks
AT brunettiantonio identificationofglomerulosclerosisusingibmwatsonandshallowneuralnetworks
AT cascaranogiacomodonato identificationofglomerulosclerosisusingibmwatsonandshallowneuralnetworks
AT bevilacquavitoantonio identificationofglomerulosclerosisusingibmwatsonandshallowneuralnetworks
AT gesualdoloreto identificationofglomerulosclerosisusingibmwatsonandshallowneuralnetworks